Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of these medicinal products is substantial. |
Clinical Added Value
| no clinical added value |
PECFENT does not provide any improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of break through pain in adult patients who take morphine drugs to treat chronic cancer pain. |
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
6SLY9TXt4d3JGHH1
